Summit Therapeutics
Clinical trials sponsored by Summit Therapeutics, explained in plain language.
-
New lung cancer drug combo aims to outperform current standard of care
Disease control Recruiting nowThis study compares two treatments for people with metastatic non-small cell lung cancer who have not had prior therapy. One group receives the experimental drug ivonescimab plus chemotherapy, while the other receives the standard drug pembrolizumab plus chemotherapy. The trial a…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New hope for colorectal cancer: experimental drug combo enters final trial phase
Disease control Recruiting nowThis study tests whether a new drug called ivonescimab, combined with standard chemotherapy, works better than the current standard treatment (bevacizumab plus chemo) for people with metastatic colorectal cancer that has spread. About 600 adults who have not had prior treatment f…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New lung cancer drug shows promise in Head-to-Head trial against keytruda
Disease control Recruiting nowThis study tests a new drug called ivonescimab against the current standard treatment, pembrolizumab (Keytruda), for people with advanced lung cancer that has spread. It includes 780 adults whose tumors have high levels of a protein called PD-L1. The goal is to see if ivonescimab…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated May 05, 2026 11:56 UTC